Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis (vol 11, e200202, 2024)

被引:1
作者
Androdias, G.
Noroy, L.
Psimaras, D.
机构
来源
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION | 2024年 / 11卷 / 03期
关键词
D O I
10.1212/NXI.0000000000200245
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In the Clinical/Scientific Note "Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis" by Androdias et al.,(1) the end of the byline should include the Societe Francophone de la Sclerose en Plaques and read "as the ICI-SEP group, under the aegis of the Societe Francophone de la Sclerose en Plaques (SFSEP)." The article has been replaced by a corrected version. The authors and editorial staff regret the omission.
引用
收藏
页数:1
相关论文
共 1 条
  • [1] Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis
    Androdias, Geraldine
    Noroy, Louise
    Psimaras, Dimitri
    Birzu, Cristina
    Pelletier, Jean
    Beigneux, Ysoline
    Branger, Pierre
    Ciron, Jonathan
    Dananchet, Yannick
    Depaz, Raphael
    Tilikete, Caroline Froment
    Gignoux, Laurence
    Grosset-Janin, Clara
    Joubert, Bastien
    Kerschen, Philippe
    Kwiatkowski, Arnaud
    Lebrun-Frenay, Christine
    Maillart, Elisabeth
    Maureille, Aurelien
    Nicolas, Philippe
    Roux, Thomas
    Marignier, Romain
    Vukusic, Sandra
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2024, 11 (02):